These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15369336)

  • 1. Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site.
    Hill CM; Li WS; Thoden JB; Holden HM; Raushel FM
    J Am Chem Soc; 2003 Jul; 125(30):8990-1. PubMed ID: 15369336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of chiral phosphate, phosphonate, and phosphinate esters by an enantioselective enzyme library.
    Nowlan C; Li Y; Hermann JC; Evans T; Carpenter J; Ghanem E; Shoichet BK; Raushel FM
    J Am Chem Soc; 2006 Dec; 128(49):15892-902. PubMed ID: 17147402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymes for the homeland defense: optimizing phosphotriesterase for the hydrolysis of organophosphate nerve agents.
    Tsai PC; Fox N; Bigley AN; Harvey SP; Barondeau DP; Raushel FM
    Biochemistry; 2012 Aug; 51(32):6463-75. PubMed ID: 22809162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
    Ghanem E; Raushel FM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversed enantioselectivity of diisopropyl fluorophosphatase against organophosphorus nerve agents by rational design.
    Melzer M; Chen JC; Heidenreich A; Gäb J; Koller M; Kehe K; Blum MM
    J Am Chem Soc; 2009 Dec; 131(47):17226-32. PubMed ID: 19894712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase.
    Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
    FEBS J; 2007 Mar; 274(5):1183-91. PubMed ID: 17286579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based and random mutagenesis approaches increase the organophosphate-degrading activity of a phosphotriesterase homologue from Deinococcus radiodurans.
    Hawwa R; Larsen SD; Ratia K; Mesecar AD
    J Mol Biol; 2009 Oct; 393(1):36-57. PubMed ID: 19631223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants for the stereoselective hydrolysis of chiral substrates by phosphotriesterase.
    Tsai PC; Fan Y; Kim J; Yang L; Almo SC; Gao YQ; Raushel FM
    Biochemistry; 2010 Sep; 49(37):7988-97. PubMed ID: 20695627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of phosphotriesterase for decontamination and detoxification of organophosphorus chemical warfare agents.
    Bigley AN; Raushel FM
    Chem Biol Interact; 2019 Aug; 308():80-88. PubMed ID: 31100274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.
    Bigley AN; Desormeaux E; Xiang DF; Bae SY; Harvey SP; Raushel FM
    Biochemistry; 2019 Apr; 58(15):2039-2053. PubMed ID: 30893549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a designed substrate analogue to diisopropyl fluorophosphatase: implications for the phosphotriesterase mechanism.
    Blum MM; Löhr F; Richardt A; Rüterjans H; Chen JC
    J Am Chem Soc; 2006 Oct; 128(39):12750-7. PubMed ID: 17002369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a phosphodiesterase capable of hydrolyzing EA 2192, the most toxic degradation product of the nerve agent VX.
    Ghanem E; Li Y; Xu C; Raushel FM
    Biochemistry; 2007 Aug; 46(31):9032-40. PubMed ID: 17630782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of stereoselectivity in phosphotriesterase.
    Hong SB; Raushel FM
    Methods Enzymol; 2004; 388():256-66. PubMed ID: 15289077
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of near active site residues in organophosphorus hydrolase reduces metal stoichiometry and alters substrate specificity.
    diSioudi B; Grimsley JK; Lai K; Wild JR
    Biochemistry; 1999 Mar; 38(10):2866-72. PubMed ID: 10074338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of substrate orientation on the mechanism of a phosphotriesterase.
    Jackson CJ; Liu JW; Coote ML; Ollis DL
    Org Biomol Chem; 2005 Dec; 3(24):4343-50. PubMed ID: 16327895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical study of the phosphotriesterase reaction mechanism.
    Chen SL; Fang WH; Himo F
    J Phys Chem B; 2007 Feb; 111(6):1253-5. PubMed ID: 17253743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of Phosphotriesterase for the Enhanced Detoxification of the Chemical Warfare Agent VR.
    Bigley AN; Mabanglo MF; Harvey SP; Raushel FM
    Biochemistry; 2015 Sep; 54(35):5502-12. PubMed ID: 26274608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution in the amidohydrolase superfamily: substrate-assisted gain of function in the E183K mutant of a phosphotriesterase-like metal-carboxylesterase.
    Mandrich L; Manco G
    Biochemistry; 2009 Jun; 48(24):5602-12. PubMed ID: 19438255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.